Terms: = Breast cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Prognosis
123 results:
1. Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis.
Nader-Marta G; Monteforte M; Agostinetto E; Cinquini M; Martins-Branco D; Langouo M; Llombart-Cusac A; Cortés J; Ignatiadis M; Torri V; Apolone G; Cappelletti V; Pruneri G; de Azambuja E; Di Cosimo S
ESMO Open; 2024 Mar; 9(3):102390. PubMed ID: 38460249
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China.
Ren M; Cai X; Jia L; Bai Q; Zhu X; Hu X; Wang Q; Luo Z; Zhou X
BMC Cancer; 2023 Dec; 23(1):1175. PubMed ID: 38041048
[TBL] [Abstract] [Full Text] [Related]
3. Genome editing approaches with CRISPR/Cas9: the association of NOX4 expression in breast cancer patients and effectiveness evaluation of different strategies of CRISPR/Cas9 to knockout Nox4 in cancer cells.
Javadi M; Sazegar H; Doosti A
BMC Cancer; 2023 Nov; 23(1):1155. PubMed ID: 38012557
[TBL] [Abstract] [Full Text] [Related]
4. The Clinical Utility of lncRNAs and Their Application as Molecular Biomarkers in breast cancer.
Arriaga-Canon C; Contreras-Espinosa L; Aguilar-Villanueva S; Bargalló-Rocha E; García-Gordillo JA; Cabrera-Galeana P; Castro-Hernández C; Jiménez-Trejo F; Herrera LA
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108589
[TBL] [Abstract] [Full Text] [Related]
5. GATA Binding Protein 3 (GATA-3) expression evaluation as prognostic factor in breast cancer and its relationship with other immunemarkers.
Tabriz HM; Farmani E; Nazar E; Javadi AE
Indian J Pathol Microbiol; 2023; 66(2):286-290. PubMed ID: 37077069
[TBL] [Abstract] [Full Text] [Related]
6. ZNF503 combined with gata3 is a prognostic factor in triple-negative breast cancer.
Liu S; Cao X; Li J; Liu J
Biomarkers; 2023 Dec; 28(5):437-447. PubMed ID: 37036735
[TBL] [Abstract] [Full Text] [Related]
7. GATA-3 expression in breast cancer is related to intratumoral M2 macrophage infiltration and tumor differentiation.
Oda H; Hedayati E; Lindström A; Shabo I
PLoS One; 2023; 18(3):e0283003. PubMed ID: 36996051
[TBL] [Abstract] [Full Text] [Related]
8. CRISPR/Cas9 screen uncovers functional translation of cryptic lncRNA-encoded open reading frames in human cancer.
Zheng C; Wei Y; Zhang P; Xu L; Zhang Z; Lin K; Hou J; Lv X; Ding Y; Chiu Y; Jain A; Islam N; Malovannaya A; Wu Y; Ding F; Xu H; Sun M; Chen X; Chen Y
J Clin Invest; 2023 Mar; 133(5):. PubMed ID: 36856111
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological Features and prognosis of Gastrointestinal Metastases From breast Carcinoma: A Clinicopathological Study of 22 Patients.
Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
[No Abstract] [Full Text] [Related]
10. Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.
Luen SJ; Viale G; Nik-Zainal S; Savas P; Kammler R; Dell'Orto P; Biasi O; Degasperi A; Brown LC; Láng I; MacGrogan G; Tondini C; Bellet M; Villa F; Bernardo A; Ciruelos E; Karlsson P; Neven P; Climent M; Müller B; Jochum W; Bonnefoi H; Martino S; Davidson NE; Geyer C; Chia SK; Ingle JN; Coleman R; Solbach C; Thürlimann B; Colleoni M; Coates AS; Goldhirsch A; Fleming GF; Francis PA; Speed TP; Regan MM; Loi S
Ann Oncol; 2023 Apr; 34(4):397-409. PubMed ID: 36709040
[TBL] [Abstract] [Full Text] [Related]
11. gata3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors.
Reiswich V; Schmidt CE; Lennartz M; Höflmayer D; Hube-Magg C; Weidemann S; Fraune C; Büscheck F; Möller K; Bernreuther C; Simon R; Clauditz TS; Blessin NC; Bady E; Sauter G; Uhlig R; Steurer S; Minner S; Burandt E; Dum D; Marx AH; Krech T; Lebok P; Hinsch A; Jacobsen F
Pathobiology; 2023; 90(4):219-232. PubMed ID: 36649695
[TBL] [Abstract] [Full Text] [Related]
12. ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC).
Ferrando L; Vingiani A; Garuti A; Vernieri C; Belfiore A; Agnelli L; Dagrada G; Ivanoiu D; Bonizzi G; Munzone E; Lippolis L; Dameri M; Ravera F; Colleoni M; Viale G; Magnani L; Ballestrero A; Zoppoli G; Pruneri G
PLoS Genet; 2023 Jan; 19(1):e1010563. PubMed ID: 36595552
[TBL] [Abstract] [Full Text] [Related]
13. SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma.
Tan K; Mo J; Li M; Dong Y; Han Y; Sun X; Ma Y; Zhu K; Wu W; Lu L; Liu J; Zhao K; Zhang L; Tang Y; Lv Z
J Exp Clin Cancer Res; 2022 Dec; 41(1):352. PubMed ID: 36539767
[TBL] [Abstract] [Full Text] [Related]
14. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC.
Guo Q; Qiu P; Yao Q; Chen J; Lin J
Dis Markers; 2022; 2022():4964793. PubMed ID: 36157217
[TBL] [Abstract] [Full Text] [Related]
15. Effect of HER2 and Fascin expression on muscle-invasive bladder cancers: Classification by basaloid and luminal phenotypes.
Arslan AI; Karabağ S; Akgül M
Indian J Pathol Microbiol; 2022; 65(3):604-609. PubMed ID: 35900488
[TBL] [Abstract] [Full Text] [Related]
16. MicroRNA-449a Inhibits Triple Negative breast cancer by Disturbing DNA Repair and Chromatid Separation.
Vajen B; Bhowmick R; Greiwe L; Schäffer V; Eilers M; Reinkens T; Stalke A; Schmidt G; Fiedler J; Thum T; DeLuca DS; Hickson ID; Schlegelberger B; Illig T; Skawran B
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563522
[TBL] [Abstract] [Full Text] [Related]
17. gata3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
Bianco G; Coto-Llerena M; Gallon J; Kancherla V; Taha-Mehlitz S; Marinucci M; Konantz M; Srivatsa S; Montazeri H; Panebianco F; Tirunagaru VG; De Menna M; Paradiso V; Ercan C; Dahmani A; Montaudon E; Beerenwinkel N; Kruithof-de Julio M; Terracciano LM; Lengerke C; Jeselsohn RM; Doebele RC; Bidard FC; Marangoni E; Ng CKY; Piscuoglio S
Commun Biol; 2022 Apr; 5(1):373. PubMed ID: 35440675
[TBL] [Abstract] [Full Text] [Related]
18. Mammaglobin, GATA-binding protein 3 (gata3), and epithelial growth factor receptor (EGFR) expression in different breast cancer subtypes and their clinical significance.
Kong X; Wang Q; Li J; Li M; Deng F; Li C
Eur J Histochem; 2022 Apr; 66(2):. PubMed ID: 35388661
[TBL] [Abstract] [Full Text] [Related]
19. [Diagnostic value of combined application of gata3, SOX10 and p16 in triple negative breast carcinomas].
Zhang DM; Zhai CJ; Feng XD; Wang CZ; Qiu JF; Wei JG
Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(10):735-740. PubMed ID: 35280018
[No Abstract] [Full Text] [Related]
20. gata3 positivity is associated with poor prognosis in patients with oesophageal squamous cell carcinoma.
Chi Z; Balani J; Gopal P; Hammer S; Xu J; Peng L
J Clin Pathol; 2023 Jul; 76(7):474-479. PubMed ID: 35039449
[TBL] [Abstract] [Full Text] [Related]
[Next]
